News About: Pharm. Industry
Salsarazine enjoys high popularity
Huons said its herbal obesity treatment Salsarazine is drawing customers' attention thanks much to aggressive media advertisements.
Launched in April of last year, Salsarazine has expanded a firmer presence in the ...
Next-generation fusion technology institute to be completed in January
The nation's next-generation fusion technology institute is poised to take a big step toward in its long-awaited goal of being a center for convergent study and research of new chemical entities.
The institute is s...
Shinpoong aims to complete two cGMP factories
Shinpoong Pharm says it plans to complete the construction of two cGMP factories within this year, aiming at its local production of antimalaria drugs and cephalosporin antibiotics with a budget of 60.0 billion won.
...
Norvasc price to be reduced in March
The Ministry of Health and Welfare says health insurance price of Norvasc (amlodipine besylate) will likely be lowered in March as revised terms for health insurance allowance are yet to be finalized.
Now that Kukj...
Wholesalers to look for new business model
The Korean Association of Pharmaceutical Wholesalers says it will develop a new business model, bolstering its presence in the domestic wholesaling industry in the face of rapidly changing environments, such as joint ...
BMS seeks health insurance allowance for new antitumor agent
BMS Korea says it plans to negotiate with the Ministry of Health and Welfare over the insurance price of its Sprycel (dasatinib), an oral inhibitor of multiple tyrosine kinases.
The company failed to reach an agree...
Drug wholesalers advocate unified distribution system
The government should support local drug wholesalers by supporting the current unified distribution system, according to the Korean Association of Pharmaceutical Wholesalers.
During a recent meeting with the Minist...
Pfizer Korea to sue Kukje Pharm for amlodipine patent infringement
Pfizer Korea will likely to file a lawsuit against Kukje Pharm's amlodipine besylate generic for infringement of its Norvasc patent.
Pfizer Korea will seek a court injunction for kukje's Norvasc generic drug, accor...
Number of patent applications for nano-liposome drugs increases steadily
Nanotechnology has become a topic of widespread discussion amongst researchers, in the media, among the investment community and elsewhere. While there is certainly a degree of hyperbole in some of this enthusiasm, it...
Small package drug makers troubled by excessive stocks
The majority of small-packet pharmaceuticals remains in idle stock, according to data revealed by the Korea Pharmaceutical Manufacturers Association (KPMA).
The association found that of the 4,476 drugs in small pa...
